Wikijet 10mg/0.5ml Pre-Filled Syringe

✔️ Side Effects

• Nausea and vomiting
• Diarrhoea or constipation
• Upset stomach, bloating, or heartburn
• Decreased appetite

✔️ Obesity

Obesity is a condition characterised by excessive accumulation of body fat that may increase the risk of conditions such as type 2 diabetes, high blood pressure, cardiovascular disease, and certain cancers. Management may include dietary changes, regular physical activity, behavioural modifications, and prescription medicines when appropriate.

✔️ Type 2 Diabetes Mellitus

Type 2 diabetes mellitus is a chronic condition in which the body does not use insulin effectively and may not produce enough insulin to maintain normal blood glucose levels. Common symptoms can include increased thirst, frequent urination, increased hunger, fatigue, blurred vision, and slow wound healing.

✔️ Diet & Lifestyle Advice

• Eat smaller portions: Smaller meals may help reduce nausea, bloating, and uncomfortable fullness.
• Stop eating when comfortably full: Avoid continuing to eat after feeling full, as this may worsen nausea or vomiting.
• Stay hydrated: Drink adequate fluids, particularly if you experience vomiting or diarrhoea, to help prevent dehydration.
• Limit high-fat foods: Fried and very fatty foods may worsen nausea or other gastrointestinal discomfort.
• Exercise regularly: Combine appropriate aerobic activity with strength-training exercises to support overall health and help maintain muscle mass during weight loss.
• Follow a balanced diet: Continue following the reduced-calorie, nutritionally balanced eating plan recommended by your healthcare professional.

✔️ Uses of Tirzepatide

Type 2 Diabetes Mellitus

Tirzepatide is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It enhances the incretin response and may produce clinically meaningful reductions in blood glucose and HbA1c levels.

Chronic Weight Management

Tirzepatide may be used for chronic weight management in eligible adults with obesity or overweight accompanied by weight-related medical conditions. By reducing appetite and increasing satiety, it can support reduced-calorie food intake and weight loss when combined with diet and physical activity.

✔️ Drug Interactions

Insulin and Sulfonylureas

Using tirzepatide together with insulin or sulfonylureas may increase the risk of hypoglycemia. Your doctor may adjust the dose of these medicines and recommend closer blood glucose monitoring.

Oral Medications

Because tirzepatide delays gastric emptying, it may affect the absorption of some medicines taken by mouth. Inform your doctor or pharmacist about all oral medications you use.

Oral Hormonal Contraceptives

Tirzepatide may reduce the effectiveness of oral hormonal contraceptives, particularly after treatment initiation and dose escalation. Discuss appropriate contraceptive options with your healthcare provider. Additional or non-oral contraception may be recommended during these periods.

✔️ Safety Information:

• Tirzepatide may cause hypoglycemia, particularly when used with insulin or sulfonylureas. Follow your doctor's instructions regarding blood glucose monitoring and management of low blood sugar.
• Diet, physical activity, and other lifestyle modifications remain important components of diabetes and weight management.
• Your doctor may recommend regular blood glucose and other laboratory monitoring depending on your condition and other medicines.
• Tirzepatide is not indicated for the treatment of type 1 diabetes mellitus.
• Use tirzepatide exactly as prescribed and do not change the dose without consulting your doctor.

✔️ Important Precautions

• Inspect the solution before injection: Check that the liquid is clear and colourless to slightly yellow. Do not use it if it appears cloudy, discoloured, or contains visible particles.
• Do not share injection devices: Never share a pen or syringe with another person, even if the needle has been changed.
• Rotate injection sites: Rotate between recommended injection areas such as the abdomen, thigh, or upper arm to reduce the risk of local skin problems.
• Monitor for low blood sugar: The risk of hypoglycemia may increase when tirzepatide is used with insulin or sulfonylureas. Symptoms may include sweating, shakiness, hunger, dizziness, weakness, or confusion.
• Report neck symptoms: Inform your doctor if you develop a new lump or swelling in the neck, persistent hoarseness, or difficulty swallowing.

✔️ Storage:

Keep out of the reach and sight of children. Store in a refrigerator at 2°C to 8°C. Do not freeze; protect from light. Do not use if it has been frozen. To be taken and sold only on the prescription of a registered physician.